XpresSpa Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XSPA research report →
Price Chart
About the company
XpresSpa Group, Inc. is a health and wellness enterprise primarily serving air travelers within airport environments. The company operates through three main divisions: XpresSpa, XpresTest, and Treat.
- CEO
- Scott R. Milford
- IPO
- 2010
- Employees
- 363
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on XSPA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $54.52M
- P/E
- -0.08
- PEG
- 0.00
- P/S
- 0.12
- P/B
- -1.99
- EV/EBITDA
- 0.05
- Div Yield
- 0.00%
- Gross Margin
- 30.69%
- Op Margin
- -24.14%
- Net Margin
- -82.81%
- ROE
- 317.52%
- ROIC
- -43.92%
Latest fiscal year · YoY change
- Revenue
- $29.21M-13.8%
- Gross Profit
- $7.51M-15.8%
- Op Income
- $467.00K
- Net Income
- $-28,233,000-71.2%
- EPS
- $-5.08-38.8%
- OCF Growth
- +20.8%
- FCF Growth
- +20.8%
- 52W High
- $2.19
- 52W Low
- $0.62
- 50D MA
- $0.83
- 200D MA
- $0.93
- Beta
- 2.14
- RSI (14)
- 27
- Avg Volume
- 597.29K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
XWELL said third-quarter revenue rose year over year while losses narrowed sharply, as management emphasized cost cuts, new location openings, and a shift toward a leaner operating model.· November 14, 2024
- Q3 revenue was $8.4 million, up from $7.5 million a year ago, with growth across XpresSpa/Treat, XpresTest, and Naples Wax.
- Operating loss improved to $4.8 million from $12.1 million, and net loss attributable to common shareholders improved to $4.8 million from $11.5 million.
- Management said nine-month 2024 operating expenses were down about 35% versus the same 2023 period, with cost of sales down about 6% and G&A down about 5%.
- CEO Ezra Ernst highlighted expansion plans for out-of-airport brands, including first Naples Wax opening in November and up to 10 XWELL properties by mid-2025.
- Balance sheet liquidity was described as solid, with $4.4 million in cash and cash equivalents, $11.7 million in marketable securities, and no long-term debt.
Total revenue for the third quarter of 2024 was approximately $8.4 million versus $7.5 million in the prior-year quarter. Revenue came from approximately $4.9 million from XpresSpa locations and Treat locations, approximately $3.1 million from XpresTest, and approximately $0.4 million from Naples Wax Center. Salaries and benefits were approximately $1.9 million versus $1.2 million last year; management noted the prior-year quarter included about $1 million of non-recurring ERC credit, and excluding that credit, 2024 salaries and benefits would have decreased 4% year over year. General and administrative expense was approximately $4.5 million, including over $2 million of extraordinary legal expenses, versus approximately $3 million a year ago. Total operating expenses were approximately $6.8 million versus approximately $13.2 million last year, operating loss was $4.8 million versus $12.1 million, and net loss attributable to common shareholders was $4.8 million versus $11.5 million. Cash and cash equivalents were $4.4 million, marketable securities were $11.7 million, total current assets were approximately $19.5 million, and the company reported no long-term debt. No explicit next-quarter or full-year financial guidance was given on the call; management instead pointed to continued cost discipline, execution improvements, and growth initiatives into 2025.
Ezra Ernst framed his first earnings call as CEO as a transition toward a leaner, faster decision-making structure after consolidating the dual-CEO model. He said that structure supports the company’s cost-reduction plan and its effort to return to profitability, while still pursuing growth and innovation. Strategically, he emphasized out-of-airport expansion, tech-forward spa concepts, and new transit-hub locations as the main growth themes, and he sounded constructive but disciplined.
Suzanne Scrabis focused on the quarter’s financial improvement and the balance sheet. She cited $8.4 million of revenue, $6.8 million of total operating expenses, a $4.8 million operating loss, and a $4.8 million net loss attributable to common shareholders, while also noting that the prior-year quarter benefited from a non-recurring ERC credit. She said liquidity remains solid with $4.4 million in cash and cash equivalents, $11.7 million in marketable securities, $19.5 million in current assets, and no long-term debt, and reiterated a focus on prudent cost management and improved operations.
There was no analyst Q&A after the prepared remarks; the call ended immediately after management’s comments. As a result, no specific analyst concerns or follow-up questions were raised on the call. The main guidance and commentary came from management’s prepared remarks, which centered on cost reductions, liquidity, and 2025 growth initiatives.
The positive case from this call is that XWELL is showing revenue growth while materially narrowing losses, helped by expense reductions and a leaner operating structure. Management also pointed to a pipeline of growth initiatives, including more Florida locations, a November Naples Wax opening, and a Penn Station XpresSpa planned for next year.
The company is still posting a meaningful net loss, and general and administrative expense remains elevated, including over $2 million of extraordinary legal costs in the quarter. No formal revenue or earnings guidance was provided, and management’s growth story depends on executing new openings and improving traffic and conversion at a still-small base of operations.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 92.6%
- Shares Outstanding
- 83.23M
- Float Shares
- 77.05M
of shares held by institutions
27 13F filers
Buy/sell ratio 5.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 6, 22 | Milford Scott R | buy | 22,950 |
| Dec 5, 22 | Milford Scott R | buy | 5,800 |
| Dec 1, 22 | Bernstein Bruce | buy | 33,890 |
| Nov 30, 22 | Bernstein Bruce | buy | 16,110 |
| Oct 28, 22 | Haynes Omar | other | 100,000 |
| Jun 13, 22 | Haynes Omar | other | 0 |
| Jun 13, 22 | Haynes Omar | other | 0 |
| Jun 13, 22 | Haynes Omar | other | 0 |
| Jun 13, 22 | Haynes Omar | other | 0 |
| Jun 17, 22 | Ernst Ezra | buy | 12,602.394 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our XSPA coverage
Recent articles, reports, and earnings notes.
No research on XSPA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XSPA report →XpresSpa Pivots Back From Covid Testing With A More Balanced Retail Vision
forbes.com · Sep 29
XpresSpa Group, Inc. (XSPA) CEO Scott Milford on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com · Aug 15
XpresSpa Group, Inc. (XSPA) Reports Q2 Loss, Tops Revenue Estimates
zacks.com · Aug 15
XpresSpa Group to Announce Second Quarter 2022 Financial Results on Monday, August 15
globenewswire.com · Aug 10
XpresSpa Group, Inc. (XSPA) Reports Q1 Loss, Tops Revenue Estimates
zacks.com · May 16
XpresSpa Group, Inc.'s (XSPA) CEO Scott Milford on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com · May 16
XpresSpa Group to Announce First Quarter 2022 Financial Results on May 16
globenewswire.com · May 12
Insiders Are Dumping These Penny Stocks, Look Out Below Or Buy The Dip?
pennystocks.com · Apr 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.